Sunday, Nov. 22, 2026 A Vik Media Group publication
Mongevity Longevity in Motion
Leer en español

Cancer and inequality: melanoma outcomes in England vary by area deprivation

☕ Includes a question for the family ↓

Cancer and inequalityPart of a story we are following · 4 articles · See every update
A community choir rehearses outdoors on a lakeside stage surrounded by pine trees, with an audience seated on the grass.
A community choir rehearses outdoors on a lakeside stage surrounded by pine trees, with an audience seated on the grass.Photo: Ireneu2 / Wikimedia Commons, CC0

Cancer and inequality are tied together, even in a country where everyone has access to public health care. A large new study from England shows that where a person with melanoma lives was still linked to how far along the cancer was at diagnosis and how they fared afterward.

In a study of 68,869 people diagnosed with melanoma in England between 2016 and 2020, those living in the most deprived areas were diagnosed younger, were more often diagnosed at a later stage, were less likely to receive systemic therapy and were more likely to die within one year than those in the least deprived areas.

How the study worked

Researchers used national records from England to follow 68,869 people diagnosed with malignant melanoma from 2016 to 2020. They linked cancer registry data to hospital records, death records and a national database of cancer drug treatment. They then sorted people into five groups by how deprived their neighborhood was, using a standard government index, and compared the top and bottom groups. The results were published on November 19, 2026 in the Br J Dermatol. Because this kind of study looks at records, it shows links between where people live and their outcomes, not the reasons behind them.

What they found

People in the most deprived areas were diagnosed at a younger age. The middle age at diagnosis was 62 years, compared with 67 years in the least deprived areas.

They were also found with more advanced disease more often. About 10% of people in the most deprived areas were diagnosed at stage 4b, the most advanced stage in this study, compared with about 8% in the least deprived areas.

Treatment differed too. After the researchers accounted for other differences such as age and health details, people in the least deprived areas were more likely to receive systemic therapies. These are cancer medicines that work throughout the body rather than on one spot. The abstract does not give the share of people who received this treatment in each group.

The same held for one-year survival. After the same adjustments, people in the least deprived areas were less likely to die from any cause within one year of diagnosis. The abstract does not give the share who died in each group.

The authors describe the overall pattern as modest. It is still a consistent one, running from diagnosis to treatment to survival.

What does deprivation mean here?

In this study, deprivation describes the area where a person lives, not the person alone. England uses an index that scores neighborhoods on things like income, jobs, education and health. Researchers then divide the scores into five equal groups, called quintiles. The most deprived group is the bottom fifth, and the least deprived group is the top fifth.

What is still unknown

The study does not explain why the gaps exist. It does not tell us whether later diagnosis, differences in access to treatment or something else accounts for the pattern. The authors call for more melanoma awareness, earlier detection and better access to systemic therapy for people in the most deprived areas.

This study was done in England, so its numbers do not describe the United States. It does show that universal coverage alone did not remove the gap.

What you can do today

Earlier detection is one of the things the authors point to, and you can act on that in a few minutes. Look over your skin in good light, including your back, scalp and the soles of your feet. Use your phone to take a photo of any spot you are unsure about, so you can tell later if it has changed. If a spot is new or looks different from before, book a visit with a doctor or clinic and show them the photos.

For clinicians and researchers

Design: Population-based cohort study of 68,869 patients diagnosed with malignant melanoma in England between 2016 and 2020, using registry data linked to Hospital Episode Statistics, mortality data and the SACT dataset. Comparison by Index of Multiple Deprivation quintile.

Main result: Least deprived versus most deprived quintile: after adjustment, patients were more likely to receive systemic therapy and less likely to die from any cause within one year, and both differences were statistically significant. Deprivation was associated with stage 4b disease (10% vs 8%).

Main limitation: Observational registry design: associations were adjusted for demographic and clinical covariates, but residual confounding cannot be excluded, and the abstract describes the association as modest.

How it fits: Extends earlier Mongevity coverage of cancer and inequality, which examined rural lung cancer patients and gene testing, by showing area-level deprivation gaps in melanoma care and outcomes. Cancer and inequality: rural lung cancer patients and gene testing · Cancer and inequality: a small prompt gets people to report false cancer cures

Open question: Whether targeted melanoma awareness, early detection and improved access to systemic therapy in the most deprived areas would narrow these differences in stage, treatment and one-year mortality remains to be tested.

Talk about it at home

Scientists in England looked at health records for a very large group of people who had a skin cancer called melanoma. They sorted neighborhoods into groups, a bit like sorting a giant jar of buttons into piles by color, and then compared the piles to see how people in each one were doing. This kind of study can show that two things go together, but it cannot say why.

Question for the table

Why do you think the scientists looked at the records of a huge number of people instead of just a few, and what could get mixed up if they had only looked at the families on your street?

Keep exploring

Copies this article and its questions so you can paste them into ChatGPT, Claude, Gemini or the AI you use, and keep the conversation going.

Got a question? Ask us ›

Get the best of longevity science by emailThe most useful new studies, in plain language and with the source. Free.

We'll email you once to confirm. Occasional messages from our sponsors, clearly labeled. Unsubscribe anytime. We never ask for health data.
Cite this article
AMA
Mongevity Desk. Cancer and inequality: melanoma outcomes in England vary by area deprivation. Mongevity. Published November 22, 2026. Accessed November 22, 2026. https://mongevity.science/cancer/2026/11/melanoma-outcomes-deprivation-england/
Vancouver
Mongevity Desk. Cancer and inequality: melanoma outcomes in England vary by area deprivation [Internet]. Mongevity; 2026 Nov 22 cited 2026 Nov 22]. Available from: https://mongevity.science/cancer/2026/11/melanoma-outcomes-deprivation-england/
APA
Mongevity Desk. (2026, November 22). Cancer and inequality: melanoma outcomes in England vary by area deprivation. Mongevity. https://mongevity.science/cancer/2026/11/melanoma-outcomes-deprivation-england/
For your website
<a href="https://mongevity.science/cancer/2026/11/melanoma-outcomes-deprivation-england/">Cancer and inequality: melanoma outcomes in England vary by area deprivation</a>

Free to share or quote with credit and a link.

Questions and answers

Does this study show that deprivation causes worse melanoma outcomes?
No. It looked at records and found links. It cannot say why people in more deprived areas had later diagnoses and worse outcomes.
How many people were studied?
The study included 68,869 people diagnosed with melanoma in England between 2016 and 2020.
What are systemic therapies?
They are cancer medicines that work throughout the body rather than on one spot. People in the least deprived areas were more likely to receive them.
Does this apply to the United States?
The study was done only in England, so it does not measure the US. It does show that universal health coverage did not remove the gap by itself.

Sources

  1. Br J Dermatol: Deprivation Still Costs Lives: Socioeconomic Inequalities in Melanoma Care and Outcomes in England (PMID 43053681 · DOI 10.1093/bjd/ljag500) · 2026-11-22

More on this story

Report an error